Industries > Pharma > Global Allergic Rhinitis Drugs Market 2017-2027

Global Allergic Rhinitis Drugs Market 2017-2027

Oral Antihistamines, Intranasal Corticosteroids, Intranasal Antihistamines, Immunotherapy and Vaccines

PUBLISHED: 30 May 2017
PAGES: 255
PRODUCT CODE: PHA0196
SUBMARKET: Therapeutic Drugs

Clear
WOOCS 2.2.1
SKU: PHA0196 Categories: ,

The global allergic rhinitis drugs market is expected to grow at a CAGR of 3.2% in the first half of the forecast period. The market is expected to grow at a CAGR of 3.3% from 2016-2027. The market is estimated at $11.9bn in 2016 and $13.9bn in 2021.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 255-page report you will receive 85 tables and 88 figures – all unavailable elsewhere.

The 255-page report provides clear detailed insight into the global allergic rhinitis drugs market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand new report today you stay better informed and ready to act.

Report Scope

Global Allergic Rhinitis Drugs Market forecasts from 2017-2027

• Along with revenue prediction for the overall world market for allergic rhinitis drugs, our investigation shows forecasts to 2027 for the following submarkets:
– Intranasal Antihistamines
– Intranasal Corticosteroids
– Oral Antihistamines
– Immunotherapy and Vaccines

• How will leading allergic rhinitis drugs perform to 2027 at world level? Our study forecasts individual revenues of these 27 products:
– Patanase
– Astepro
– Astelin
– Dymista
– Nasonex
– Avamys
– Veramyst
– Flixonase
– Rhinocort
– Omnaris
– Nasacort
– Beconase
– Qnasl
– Zetonna
– Allegra
– Zyrtec
– Claritin
– Xyzal
– Allelock
– Clarinex
– Ebastel
– Talion
– Staloral
– Alutard SQ
– Grazax
– Ragwitek
– Generic Azelastine

Global Allergic Rhinitis Drugs Market 2017-2027

• This report provides individual revenue forecasts to 2027 for these regional and national markets:
– US
– EU5 – Germany, UK, France, Italy and Spain
– China
– Japan
– India
– Russia
– Brazil
– Rest of the World

• Our work provides analysis and sales forecast of the leading companies in the allergic rhinitis drugs market:
GlaxoSmithKline (GSK)
– Merck & Co
– Sanofi
– Johnson & Johnson
– ALK-Abello
– UCB
– Kyowo Hako Kirin
– Stallergenes Greer

• This report discusses the trends and development in the allergic rhinitis pipeline

• Our study discusses strengths, weaknesses, opportunities and threats as well as porter’s five forces analysis of the global allergic rhinitis drugs market

Visiongain’s study is intended for anyone requiring commercial analyses for the global allergic rhinitis drugs market. You find data, trends and predictions.

Buy our report today Global Allergic Rhinitis Drugs Market 2017-2027: Oral Antihistamines, Intranasal Corticosteroids, Intranasal Antihistamines, Immunotherapy and Vaccines.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Global Allergic Rhinitis Drugs Market 2017-2027


Download sample pages

Complete the form below to download your free sample pages for Global Allergic Rhinitis Drugs Market 2017-2027


Latest Pharma news

Visiongain Publishes Rare Diseases Market Report 2021-2031

As lockdowns were imposed in all the countries, diagnosis rates went down in majority of countries during the year hitting the drug sales for some period. Although lockdown measures have been eased up in most countries by mid-year 2020, this trend is expected to continue beyond 2020, stock up of medicines by patients is likely to propel the drug sales in majority of the developed economies, which account for majority of rare diseases.

02 March 2021

READ

Visiongain Publishes Respiratory Inhalers Market Report 2021-2031

Product approval is a major milestone facing all key competitors in the respiratory inhalers market. Several strategies were implemented by key market players between 2015 and Jan 2021.

26 February 2021

READ

Visiongain Publishes Bile Duct Cancer Drugs Market Report to 2031

The global bile duct cancer drug market has been growing considerably owing to the rising incidence and prevalence rate of bile duct cancer patients worldwide, technological advancement in drug development, and healthcare spending.

22 February 2021

READ

Visiongain Publishes Big Data Analytics in Healthcare Market Report to 2031

The global Big Data Analytics in Healthcare market has been growing considerably owing to the rising technological advancement, growing investment, and cohesive government policies.

22 February 2021

READ

Categories